Cargando…

Retrospective evaluation of possible renal toxicity associated with continuous infusion of vancomycin in critically ill patients

BACKGROUND: Continuous infusion of vancomycin is increasingly preferred as an alternative to intermittent administration in critically ill patients. Intermittent vancomycin treatment is associated with an increased occurrence of nephrotoxicity. This study was designed to determine the incidence and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spapen, Herbert D, Janssen van Doorn, Karin, Diltoer, Marc, Verbrugghe, Walter, Jacobs, Rita, Dobbeleir, Nadia, Honoré, Patrick M, Jorens, Philippe G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224465/ https://www.ncbi.nlm.nih.gov/pubmed/21906376 http://dx.doi.org/10.1186/2110-5820-1-26

Ejemplares similares

Continuous infusion of antibiotics in the critically ill: The new holy grail for beta-lactams and vancomycin?
por: Van Herendael, Bruno, et al.
Publicado: (2012)

Chloride content of solutions used for regional citrate anticoagulation might be responsible for blunting correction of metabolic acidosis during continuous veno-venous hemofiltration
por: Jacobs, Rita, et al.
Publicado: (2016)

Correction to: Chloride content of solutions used for regional citrate anticoagulation might be responsible for blunting correction of metabolic acidosis during continuous venovenous hemofiltration
por: Jacobs, Rita, et al.
Publicado: (2020)

Treatment of Ventilator-associated Pneumonia with High-dose Colistin Under Continuous Veno-venous Hemofiltration
por: Spapen, Herbert, et al.
Publicado: (2019)

Continuous Vancomycin Infusion versus Intermittent Infusion in Critically Ill Patients
por: Maluangnon, Chailat, et al.
Publicado: (2022)

Intertwining extracorporeal membrane oxygenation and continuous renal replacement therapy: sense or nonsense?
por: Jacobs, Rita, et al.
Publicado: (2015)

Normal saline as resuscitation fluid in critically ill patients: not dead yet!
por: Honore, Patrick M., et al.
Publicado: (2016)

Biomarker validity in the critically ill: all must face the (continuous) renal replacement challenge!
por: Honore, Patrick M., et al.
Publicado: (2015)

The blind spot in high-dose tigecycline pharmacokinetics in critically ill patients: membrane adsorption during continuous extracorporeal treatment
por: Honore, Patrick M, et al.
Publicado: (2015)

Some metabolic issues should not be neglected when using citrate for continuous renal replacement therapy!
por: Jacobs, Rita, et al.
Publicado: (2015)

Cefepime-induced neurotoxicity in critically ill patients undergoing continuous renal replacement therapy: beware of dose reduction!
por: Honore, Patrick M., et al.
Publicado: (2015)

Propofol infusion syndrome: early blood purification to the rescue?
por: Honore, Patrick M., et al.
Publicado: (2016)

Vancomycin pharmacokinetics in critically ill obese patients: can the clinician sit back and relax?
por: Honore, Patrick M., et al.
Publicado: (2019)

Renal and neurological side effects of colistin in critically ill patients
por: Spapen, Herbert, et al.
Publicado: (2011)

Unapparent systemic effects of regional anticoagulation with citrate in continuous renal replacement therapy: a narrative review
por: Boer, Willem, et al.
Publicado: (2023)

The Duration of Hypotension Determines the Evolution of Bacteremia-Induced Acute Kidney Injury in the Intensive Care Unit
por: Janssen van Doorn, Karin, et al.
Publicado: (2014)

CO(2) and O(2) removal during continuous veno-venous hemofiltration: a pilot study
por: Jonckheer, Joop, et al.
Publicado: (2019)

Continuous infusion versus intermittent infusion of vancomycin in critically ill patients undergoing continuous venovenous hemofiltration: a prospective interventional study
por: Xu, Jinhui, et al.
Publicado: (2022)

High-frequency percussive ventilation in severe acute respiratory distress syndrome: A single center experience
por: Spapen, Herbert, et al.
Publicado: (2014)

Correction to: CO(2) and O(2) removal during continuous veno-venous hemofiltration: a pilot study
por: Jonckheer, Joop, et al.
Publicado: (2019)

‘Biomarking’ infection during continuous renal replacement therapy: still relevant?
por: Honore, Patrick M, et al.
Publicado: (2015)

A specially tailored vancomycin continuous infusion regimen for renally impaired critically ill patients
por: Eldemiry, Eman Mohamed Bahgat, et al.
Publicado: (2013)

Predictors of acute kidney injury under continuous infusion of vancomycin in critically ill surgical patients
por: Chackupurakal, R, et al.
Publicado: (2015)

Higher colistin dose during continuous renal replacement therapy: look before leaping!
por: Honore, Patrick M., et al.
Publicado: (2015)

Continuous renal replacement therapy for safe and adequate voriconazole intravenous treatment: enough reason to be confident?
por: Honore, Patrick M, et al.
Publicado: (2015)

Is neutrophil gelatinase-associated lipocalin unaffected by convective continuous renal replacement therapy? Definitely … maybe
por: Honore, Patrick M., et al.
Publicado: (2015)

Optimizing citrate dose for regional anticoagulation in continuous renal replacement therapy: measuring citrate concentrations instead of ionized calcium?
por: Honore, Patrick M., et al.
Publicado: (2015)

Colistin dosing for treatment of multidrug-resistant Pseudomonas in critically ill patients - please, be adequate!
por: Honoré, Patrick M, et al.
Publicado: (2014)

Presepsin and sepsis-induced acute kidney injury treated with continuous renal replacement therapy: will another promising biomarker bite the dust?
por: Honore, Patrick M., et al.
Publicado: (2015)

Delivering intrapulmonary percussive ventilation physiotherapy with assisted autogenic drainage is associated with a lower incidence of ventilator-associated gram-negative infection
por: Borremans, M, et al.
Publicado: (2015)

Prognosis of extremely severe lactic acidosis in metformin-treated patients with septic shock: continuous (?) renal replacement therapy in the spotlight!
por: Honore, Patrick M., et al.
Publicado: (2016)

Regional Citrate Anticoagulation in Continuous Renal Replacement Therapy: Is Metabolic Fear the Enemy of Logic? A Systematic Review and Meta-Analysis of Randomised Controlled Trials
por: Jacobs, Rita, et al.
Publicado: (2023)

Disturbance of Vancomycin Infusion Flow during Multidrug Infusion: Influence on Endothelial Cell Toxicity
por: Drouet, Maryline, et al.
Publicado: (2021)

Dosing adjuvant vitamin C in critically ill patients undergoing continuous renal replacement therapy: We are not there yet!
por: Honore, Patrick M., et al.
Publicado: (2019)

Acute respiratory muscle weakness and apnea in a critically ill patient induced by colistin neurotoxicity: key potential role of hemoadsorption elimination during continuous venovenous hemofiltration
por: Honore, Patrick M, et al.
Publicado: (2013)

Vancomycin continuous infusion versus intermittent infusion during continuous venovenous hemofiltration: slow and steady may win the race
por: Lin, Hsin, et al.
Publicado: (2015)

Efficacy and Safety of Continuous Infusion of Vancomycin in Children: A Systematic Review
por: Alonso-Moreno, Marta, et al.
Publicado: (2021)

Anidulafungin dosing during CRRT: do not underestimate adsorption!
por: Honore, Patrick M, et al.
Publicado: (2014)

New generation indirect calorimeters for measuring energy expenditure in the critically ill: a rampant or reticent revolution?
por: De Waele, Elisabeth, et al.
Publicado: (2016)

Biomarkers in critical illness: have we made progress?
por: Honore, Patrick M, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_l9a0l0poa79n4ql7qcoe8lev95